In our studies, native IFNα treatment was ineffective in tumor cell models based on subcutaneous xenograft implants (Fig 5), whereas, native IFNα showed strong anti-tumor activity in the two LAG xenograft models which were based on in vivo passaged MM tumor fragments implanted intramuscularly (Fig 1). Here, IFNA2 is linked to Miyoshi myopathy.